Viking Therapeutics Is A Buy For Some Investors, But Beware The Sizeable Risks

Like some other analysts, I believe that, due to the strong efficacy of Viking Therapeutics, Inc. (NASDAQ: VKTX ) weight-loss drug, VK2735, the company will probably eventually be acquired by a large pharmaceutical firm. But I think (after conducting extensive Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I a ...